메뉴 건너뛰기




Volumn 5, Issue 4, 2008, Pages 232-235

Drug design should involve consideration of environmental risk and hazard

Author keywords

Drug legislation; Environment; Hazard assessment; Human drugs; Risk assessment; Sewage water

Indexed keywords

ATENOLOL; CETIRIZINE; CIPROFLOXACIN; CODEINE; DICLOFENAC; FUROSEMIDE; IBUPROFEN; KETOPROFEN; LOSARTAN; METOPROLOL; NAPROXEN; PARACETAMOL; SULFAMETHOXAZOLE; TRAMADOL;

EID: 45249098945     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018008784619942     Document Type: Article
Times cited : (8)

References (9)
  • 6
    • 45249120304 scopus 로고    scopus 로고
    • The website published by the Swedish Association of the Pharmaceutical Industry
    • www.fass.se The website published by the Swedish Association of the Pharmaceutical Industry.
  • 8
    • 45249119666 scopus 로고    scopus 로고
    • OECD Test Guidelines for Testing of Chemicals (see http://www.oecd.org/).
    • OECD Test Guidelines for Testing of Chemicals (see http://www.oecd.org/).
  • 9
    • 45249100810 scopus 로고    scopus 로고
    • Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use, http://ec.europa.eu/enterprise/ pharmaceuticals/ eudralex/1/dir_2004_27/dir_2004_27_en.pdf.
    • Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use, http://ec.europa.eu/enterprise/ pharmaceuticals/ eudralex/vol-1/dir_2004_27/dir_2004_27_en.pdf.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.